Esperion Therapeutics | ESPR - Ordinary Share Capital

Stock Price
2.78
Daily Change
0.16 5.92%
Monthly
-17.41%
Yearly
70.25%
Q1 Forecast
2.47

Esperion Therapeutics reported $245.22M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Alterity Therapeutics Limited AUD 213.97M 144.39K Jun/2023
Amarin USD 20.81M 13K Dec/2025
Amgen USD 539M 1000K Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Cipla INR 807.77M 807.43M Sep/2025
CSL USD 482.13M 93.87M Dec/2025
Cytokinetics USD 122.26M 145K Dec/2025
Daiichi Sankyo JPY 1.85B 9K Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Geron USD 638.36M 338K Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Ionis Pharmaceuticals USD 161.97M 836K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Moderna USD 391M 2M Sep/2025
Nektar Therapeutics USD 19K 0 Sep/2024
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Puma Biotechnology USD 5K 0 Jun/2024
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Sarepta Therapeutics USD 104.96M 196K Dec/2025
United Therapeutics USD 43.64M 740K Dec/2025
Vanda Pharmaceuticals USD 58K 0 Dec/2024